Skip to content
lifestyle.marketresearchjournals.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
POMDOCTOR LIMITED
POMDOCTOR LIMITED Announces Receipt of Nasdaq Notifications Regarding Continued Listing Requirements
November 2, 2026
POMDOCTOR LIMITED Announces the Termination of Its ADR Program and Trade Class A Ordinary Shares on Nasdaq
October 19, 2026
POMDOCTOR LIMITED Highlights the Shift from Reactive Treatment to Predictive Healthcare
October 12, 2026
POMDOCTOR LIMITED Announces Receipt of Nasdaq Staff Delisting Determination
October 9, 2026
Healthcare Optimization via AI-Enabled Chronic Disease Management with Real World Data Commercialization Infrastructure from Pomdoctor, LTD. (NASDAQ: POM)
October 1, 2026
POMDOCTOR LIMITED Accelerates AI-Enabled Chronic Disease Management and RWD Commercialization
September 30, 2026
POMDOCTOR LIMITED Highlights Differentiated “Hardware + AI + Payment” Healthcare Infrastructure Model
September 24, 2026
POMDOCTOR LIMITED to Participate in H.C. Wainwright’s 28th Annual Global Investment Conference
September 10, 2026
POMDOCTOR LIMITED Initiates U.S. Market Preparation and Unveils Expansion Strategy
August 27, 2026
POMDOCTOR LIMITED Highlights Healthcare Intelligence Flywheel as a Self-Reinforcing Growth Engine
August 10, 2026
1
2
Next Page
→